Medicon Valley Alliance are pleased to invite you to an exclusive Good Morning Meeting hosted by Theradex Oncology and Simsen Diagnostics on 18h of November 2025. Designed specifically for pharmaceutical companies developing cancer therapies, this gathering offers an opportunity to gain actionable insights and explore innovative solutions for oncology clinical trials. Sharing the latest strategies […]

Medicon Valley Alliance and Smithers would like to welcome you to a Good Morning Meeting 26th of November 2025. Design verification of combination pharmaceutical–medical devices is a critical step in ensuring regulatory compliance and product performance. This seminar on parenteral delivery systems explores best practices for developing robust strategies, aligning with regulatory requirements, and testing […]

Medicon Valley Alliance and Fios Genomics are pleased to invite you to a Good Morning Meeting on the 28th of October 2025 in Copenhagen. The road to new therapies is long, costly, and full of risk, but smarter use of data can change the odds. This session will explore how bioinformatics can drive success in […]

Medicon Valley Alliance and Capish are pleased to invite you to a Good Morning Meeting on the 22th of October 2025 in Copenhagen. In drug development, data quality is not just a box to tick — it is the backbone of regulatory success and patient safety. Poorly managed data can result in delayed approvals, critical […]

Medicon Valley Alliance and Svar Life Science would like to welcome you to a Good Morning Meeting 21st of October 2025. As regulatory expectations continue to evolve, the demand for potency assays that accurately reflect a drug’s mechanism of action has never been greater. Potency must be tightly controlled, recognized as a critical quality attribute […]

How today’s innovators are tackling difficult cancer targets, refining models, and advancing ethical, effective drug development Learn more about our innovative oncology R&D, integrating scientific expertise with the 3Rs: Replace, Reduce, Refine of animal use in research for ethical responsibility. Featuring ChemPartner’s end-to-end platforms, case studies on KRAS G12C inhibitors and HER2 x TROP2 bispecific […]

Medicon Valley Alliance and Cencora PharmaLex are pleased to invite you to a Good Morning Meeting on the 18th of September 2025 in Copenhagen focusing on regulatory digital initiatives in the EU. Let’s discuss about regulatory digital initiatives in the EU such as ePI, eAF, IRIS and PMS. – Key challenges in pharmaceutical product lifecycle […]

Medicon Valley Alliance and BioAgilytix would like to welcome you to a Good Morning Meeting 9th of September 2025. In recent years, we have seen changes in regulations that affect bioanalytical strategies for drug development. Moving towards using leaner approaches, building in efficiencies, and simplifying overall strategies with the ultimate goal of reducing the time […]

Medicon Valley Alliance and TFS would like to welcome you to a Good Morning Meeting on the 18th of June 2025. Pharmacovigilance (PV) is a dynamic and essential part of ensuring post-marketing safety, especially as regulations evolve and new data types emerge. In this session, we’ll explore the critical steps involved in setting up a […]

Medicon Valley Alliance and Pharmaron would like to welcome you to a Good Morning Meeting 11th of June 2025. Imagine trying to discover and develop a medicine without knowledge of its metabolism and pharmacokinetic properties, or being able to contextualise drug behaviour across species using a range of computational, in vitro and in vivo approaches? […]

Medicon Valley Alliance and Smithers would like to welcome you to a Good Morning Meeting 4th of June 2025. The assessment of extractables and leachables (E&L) on pharmaceutical products, medical devices, delivery systems, and processing equipment have continued to evolve. This aligns with the expanding exposure of polymeric materials to patients, resulting in the path […]

Medicon Valley Alliance and Servier are delighted to invite you to Servier’s 2025 R&D Partnering Day in The Nordics Servier is one of the leading French pharmaceutical companies. We have a long-standing commitment to external collaborations, particularly in oncology, neurology and technology platforms, to bring innovative medicines to patients. With our presence in Denmark through […]

Medicon Valley Alliance and PCI would like to welcome you to a Good Morning Meeting 20th of May 2025. The pharmaceutical industry is undergoing a rapid transformation driven by scientific breakthroughs, evolving regulatory landscapes, and the demand for more targeted, patient-centric therapies. Innovation in the Pharmaceutical World will spotlight key advancements shaping the future of […]

Medicon Valley Alliance and Clario would like to welcome you to a Good Morning Meeting 7th of May 2025. Discover an informative seminar delving into the transformative role of artificial intelligence (AI) in clinical trials: where the industry is currently at, common misconceptions in leveraging AI, proactively tackling the potential for bias and navigating the […]

Medicon Valley Alliance and Potter Clarkson would like to welcome you to a Good Morning Meeting 6th of February 2025. Innovation in digital therapeutics is booming as the possibilities offered by AI, an increased appetite to work across technologies and the growing power of data look set to help this market’s value rocket from $6.5bn […]

Medicon Valley Alliance and Fortrea would like to welcome you to a Good Morning Meeting 6th of November 2024. Join us for an insightful exploration of the evolving clinical research landscape as our expert speakers delve into how digital health, technology, and AI are enhancing clinical development productivity. Gain a deeper understanding of the positive […]

Medicon Valley Alliance and Quotient Science would like to welcome you to a Good Morning Meeting 24th of October 2024. Drug product optimization is a critical development step that is common for most drugs that are progressing through today’s development pipelines to respond to suboptimal exposure profiles, to transition from an early development formulation to […]

Medicon Valley Alliance and Kvantify would like to welcome you to a Good Morning Meeting 26th of September 2024. Our upcoming presentation will explore the transformative role of computational methods in drug discovery, which save time, conserve resources, and enhance efficiency in drug discovery pipelines. We’ll demonstrate how novel physics-based methods, rooted in physical principles, […]

Medicon Valley Alliance and Menarini Biotech would like to welcome you to a Good Morning Meeting 25 th of September 2024. Menarini Biotech brings over 20 years of expertise in antibody and bioconjugation drug substance development, formulation, and drug product manufacturing to biotech companies everywhere. If you’re working with antibodies and looking to accelerate your […]

Medicon Valley Alliance and GemPharmatech would like to welcome you to a Good Morning Meeting 24th of September 2024. In the fast-paced world of drug development, timing is everything, and the expertise of your research partner can make or break your project. Join us for an exclusive event designed to help you master the art […]

Medicon Valley Alliance and IQVIA would like to welcome you to a Good Morning Meeting 5th of September 2024. Real world evidence (RWE) is becoming increasingly important throughout the product lifecycle. Once considered optional, it is now a necessity. With increasing focus from both regulatory and market access stakeholders, RWE requirements need to be planned […]

Medicon Valley Alliance and Quotient Sciences would like to welcome you to a Good Morning Meeting. In this presentation, Dr. Andrew Parker will discuss transitioning from pre-clinical to clinical stages, covering regulatory expectations and enabling technologies for poorly soluble molecules. He will also showcase solutions developed by our team using the Quotient Sciences Translational Pharmaceutics® […]

Medicon Valley Alliance and PharmaLex are pleased to invite you to a Good Morning Meeting on the 11th of June in Copenhagen focusing on How to help being compliant with EU GMP Annex 1 – A practical perspective. The EU GMP Annex 1 “Manufacture of Sterile Medicinal Products” came into effect as of August 2023, […]

Medicon Valley Alliance and PharmaLex are pleased to invite you to a Good Morning Meeting on the 7th of June in Copenhagen. Clinically developing targeted therapies is considered a complex and time-consuming process, requiring a deep understanding of disease biology and the molecular mechanisms driving disease. But the complexities go far beyond the science. Targeted […]

Medicon Valley Alliance and BioAgilytix would like to welcome you to a Good Morning Meeting. In the realm of biotherapeutics, which include a diverse array of antibodies, proteins, hormones, enzymes and peptides, understanding and managing immunogenicity is of paramount importance. As biotherapeutic modalities increase in complexity, so too does the immunogenicity assessment strategy and the […]

Medicon Valley Alliance and Celerion would like to welcome you to a Good Morning Meeting. Abstract: Transitioning an experimental drug from preclinical animal models to the clinic is a critical milestone in bringing new medications to the market. First-in-Human (FiH) clinical studies have undergone a significant evolution, from a basic “feed-and-bleed” model in the 1970s, […]

Medicon Valley Alliance and Syneos are pleased to invite you to a Good Morning Meeting on the 13th of March in Copenhagen focusing on: Navigating the current funding environment and other key challenges in drug development for 2024 and beyond. An overview of the recent dynamic environmental, economic, regulatory and payer developments which are creating […]